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Abstract
Background: Streptococcus suis serotype 2 (S. suis 2) is an important pathogen of pigs. S suis 2 infections have
high mortality rates and are characterized by meningitis, septicemia and pneumonia. S. suis 2 is also an emerging
zoonotic agent and can infect humans that are exposed to pigs or their by-products. To increase our knowledge
of the pathogenesis of meningitis, septicemia and pneumonia in pigs caused by S. suis 2, we profiled the response
of peripheral blood mononuclear cells (PBMC), brain and lung tissues to infection with S. suis 2 strain SC19 using
the Affymetrix Porcine Genome Array.
Results: A total of 3,002 differentially expressed transcripts were identified in the three tissues, including 417
unique genes in brain, 210 in lung and 213 in PBMC. These genes showed differential expression (DE) patterns on
analysis by visualization and integrated discovery (DAVID). The DE genes involved in the immune response
included genes related to the inflammatory response (CD163), the innate immune response (TLR2, TLR4, MYD88,
TIRAP), cell adhesion (CD34, SELE, SELL, SELP, ICAM-1, ICAM-2, VCAM-1), antigen processing and presentation (MHC
protein complex) and angiogenesis (VEGF), together with genes encoding cytokines (interleukins). Five selected
genes were validated by qRT-PCR analysis.
Conclusions: We studied the response to infection with S. suis 2 strain SC19 by microarray analysis. Our findings
confirmed some genes identified in previous studies and discovered numerous additional genes that potentially
function in S. suis 2 infections in vivo. This new information will form the foundation of future investigations into
the pathogenesis of S. suis.
Background
Streptococcus suis (S. suis 2) is an important pathogen of
pigs that causes high mortality and is responsible for con-
siderable economic loss to the porcine industry [1]. Sero-
type 2 is considered the most virulent form of the bacteria
and is the serotype most frequently isolated from diseased
animals [2]. S. suis 2 is also an emerging zoonotic agent
and has been isolated from a wide range of mammalian
species, including humans, who are often infected via skin
wounds during contact with pigs and their products [3].
S. suis 2 is frequently isolated from asymptomatic pigs,
especially adult pigs (young pigs are susceptible to the dis-
ease), which indicates that pigs can be carriers of S. suis 2.
Two outbreaks in humans have been documented in
China, in 1999 and 2005; hundreds of people were infected
and 52 died. Human illness following S. suis infection has
also been reported in Thailand [4], the United Kingdom
[5], the Netherlands [6], Australia [7] and the United
States [8]. Moreover, in Hong Kong, infection with S. suis
is the third most common cause of community-acquired
bacterial meningitis, and in Vietnam it is the leading cause
of meningitis in adult humans [9].
Previous studies of the pathogenesis of S. suis infection
focused on the virulence factors of S. suis 2. The capsular
polysaccharide (CPS), muramidase-released protein
(MRP), extracellular protein factor (EF) and suilysin (SLY)
are considered to be virulence-associated factors that play
an important role in the process of infection with S. suis 2.
In the Chinese strains, an 89 kb pathogenicity island (PAI)
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isolates [10].
Essentially, the disease is the result of the interaction
between the bacteria and the host, and we believe further
investigation of the host response to infection with S. suis
2 will help us to better understand the disease. Several
previous studies have shown that S. suis 2 can adhere to
various types of epithelial cell [11] and to microvascular
endothelial cells from porcine brain [12,13]. In addition,
the response of alveolar macrophages to S. suis 2i n f e c -
tion is associated with induction of the nuclear factor-
kappa B (NF-B) and MAP-kinase signaling pathways.
Further study has found that THP-1 cells respond to
infection with S. suis 2 by changes in the level of expres-
sion of TLR2 and CD14. The Toll-like receptors (TLRs)
have been shown to recognize a wide range of microbial
components and mediate responding cellular signaling.
CD14 has been shown to be important in the recognition
of LPS (lipopolysaccharide) [14]. The CD14 receptor is
also known to interact with members of the TLR family.
The receptors share common signaling pathways that
trigger the association of adaptor molecules, such as
myeloid differentiation factor 88 (MyD88), with several
kinases, leading to the nuclear translocation of NF-B.
These findings indicate that these pattern recognition
receptors may play a role in the host interaction with
S. suis 2. The purpose of our studies was to evaluate the
interaction of the PBMC, brain and lung of pigs with
S. suis 2, and thereby facilitate further investigations on
the pathogenesis of S. suis 2.
Results
Transcription analysis
In this study, differential gene expression was investigated
among the three tissues studied (PBMC, brain and lung).
Transcript analysis indicated that at least 48.19% and up
to 67.89% of the probe sets were well detected in all 18
samples. The criteria of fold change (FC) ≥ 2 and p value
≤0.05 were considered to indicate up-regulation; FC ≤ 0.5
and p ≤ 0.05 were considered to represent down-regula-
tion. Genes whose relative transcription levels were
between 0.5 and 2 were considered to show no significant
change. As shown in Figure 1, 1608 genes in the brain
showed changes, including 344 genes up-regulated and
1264 genes down-regulated. There were 617 genes were
changed in the lung, 293 up-regulated and 324 down-
regulated and 685 genes were changed in PBMC, 403 up-
regulated and 282 down-regulated. The expression of 31
genes was found to change in response to infection in all
three tissues, comprising 26 genes up-regulated and 5
genes down-regulated.
All differentially expressed (DE) genes were annotated
o nt h eb a s i so ft h eg e n eo n t o l o g y( G O )d a t a b a s eu s i n g
Visualization and Integrated Discovery (DAVID). In
brain tissue, of the 1608 DE transcripts, 460 were anno-
tated by DAVID and these represented 417 unique genes.
In the lung, 240 transcripts were annotated, which repre-
sented 210 unique genes of the 617 DE transcripts. In
PBMC, of the 685 DE transcripts, 248 transcripts were
annotated and represented 213 unique genes.
Figure 2 lists 17 categories of genes divided on the basis
of gene ontology (GO), including those associated with
the defense response, immune response, inflammatory
response, innate immune response, cell adhesion, cell
death, cell differentiation, cell surface receptor linked sig-
nal transduction, cytokine activity, cytokine binding,
response to external stimuli, response to stimulus,
response to stress, response to wounding, signal transdu-
cer activity, gene expression and growth factor activity.
Quantitative RT-PCR to validate the microarray data
To validate the DE genes identified in the microarray
data, quantitative RT-PCR (qRT-PCR) analysis was per-
formed on the same samples that were used in the
microarray. Three up-regulated genes and two down-
regulated genes were selected for validation (Table 1).
The three up-regulated genes analyzed were CD163
(cluster of differentiation 163), ICAM-1 (inter-cellular
adhesion molecule 1) and TLR2; all three showed higher
expression in infected groups tissues than in the control
groups. Of the two down-regulated genes analyzed,
VEGFA (vascular endothelial growth factor A) was
f o u n dt ob ed o w n - r e g u l a t e di nt h el u n ga n dT T R
Figure 1 Number of genes expressed differentially in brain,
lung and PBMC. The number of genes found to be differentially
expressed in each of the tissues is shown in the circles. The grey
circle represents the number of genes in the brain, tinted grey
represents the PBMC and deep grey circle represents the lung. A.
Number of DE genes including up-regulated and down-regulated. B.
Number of up-regulated genes. C. Number of down-regulated
genes.
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brain and PBMC. Contrasting results were seen for
V E G F Ai nt h eb r a i na n dP B M Ca n dT T Ri nt h el u n g .
These contradictions between the qRT-PCR results and
the microarray may arise from the qRT-PCR technique
being more sensitive and accurate or that the primer
design methods and the dynamic range were different.
Induction of genes related to the innate immune
response
Analysis of the expression of porcine genes in three tissues
after infection with S. suis 2 showed that a large set of DE
genes is involved in the immune response. TLR signaling
plays an essential role in the innate immune response.
TLR2 (up-regulated between 2.4- and 3.9-fold in the three
Figure 2 Categories of genes divided on the basis of Gene Ontology (GO). Many categories shared the same transcripts
Liu et al. BMC Genomics 2011, 12:253
http://www.biomedcentral.com/1471-2164/12/253
Page 3 of 12tissues) and TLR4 (up-regulated 2- to 4.3-fold in brain and
PBMC but not lung) both belong to the TLR family and
are expressed most abundantly in peripheral blood leuko-
cytes. They mediate the host response to Gram-positive
bacteria and play a fundamental role in pathogen recogni-
tion and activation of innate immunity. Another receptor
for bacteria, CD14 (up-regulated 2- to 3-fold in the three
tissues) recognizes LPS of Gram-negative bacteria and
cooperates with TLR4 (which also recognizes LPS) via
MYD88, leading to inflammatory responses. In addition,
LY96 (MD-2) (up-regulated 2.3-fold in brain) plays a role
in the recognition of LPS together with TLR2 or TLR4.
Moreover, CD14 has also been found to recognize pepti-
doglycan (PGN) of Gram-positive bacteria and to be were
associated with SS2 [15]. The signal transducer MYD88
(up-regulated 2- to 3.4-fold in brain and lung and 1.9-fold
in PBMC) is an adapter for almost all TLR (except TLR3)
signaling pathways, and acts via interferon regulatory fac-
tor 7 (IRF7, up-regulated approximately 2-fold in brain
and lung), leading to activation of NF-kappa-B, cytokine
secretion and the inflammatory response. CXCL9 (chemo-
kine (C-X-C motif) ligand 9, otherwise known as MIG;
up-regulated 18.8-fold in brain and 8.4-fold in lung) is
thought to be induced by gamma interferon (IFN-g)a n d
binds to CXCR3, which activates the chemotactic func-
tions of CXCL10 and CXCL11.
Induction of genes associated with the inflammatory
response
The inflammatory response is part of the initial defensive
reaction against infection or injury caused by chemical or
physical agents. Several DE genes in this study are
involved in the inflammatory response, including CD163,
AMCF-II, CCL2 and CCL4. The expression of hemoglobin
scavenger receptor CD163 (M130) was up-regulated more
than 4-fold in all three tissues. This has been identified as
a receptor that might play a role in immunoregulation and
m a yb eav a l u a b l ed i a g n o s t i cparameter for monitoring
macrophage activation in inflammatory conditions.
Another scavenger receptor, AMCF-II (alveolar macro-
phage-derived chemotactic factor-II, up-regulated 3.6-fold
in lung), has chemotactic activity for porcine cells and can
be induced by LPS. It belongs to the intercrine alpha (che-
mokine CxC) family; its new designation is CXCL5 and
the gene symbol is SCYB5. Cytokine CCL2 (chemokine
(C-C motif) ligand 2, up-regulated 12.6-fold in brain) is
thought to bind to chemokine receptors CCR2 and CCR4.
CCL4 (chemokine (C-C motif) ligand 4, up-regulated
2.41-fold in brain and 3.88-fold in lung) is a CC chemo-
kine with specificity for CCR5 (up-regulated 4-fold in
PBMC) receptors. CD1D (down-regulated 2.72-fold in
PBMC and 2.49-fold in lung) encodes a divergent member
of the CD1 family of transmembrane glycoproteins, which
are structurally related to the major histocompatibility
complex (MHC) proteins andf o r mh e t e r o d i m e r sw i t h
beta-2-microglobulin (B2M, down-regulated 3.54-fold in
brain and 2.98-fold in lung).
Genes associated with cell adhesion
Cell adhesion molecules (CAMs) perform various func-
tions in fundamental cellular processes, including polariza-
tion, movement, proliferation and survival [16]. We
discovered several DE genes that were related to cell adhe-
sion during S. suis 2 infection, including CD34, ICAM-1,
ICAM-2, VCAM-1, SELE, SELL and SELP. CD34 (CD34
molecule, down-regulated 2.36-fold in lung) is a mono-
meric cell surface antigen that is expressed selectively on
human hematopoietic progenitor cells. It plays a role in
early hematopoiesis by mediating the attachment of stem
cells to the bone marrow extracellular matrix or directly
to stromal cells, and was found as a carbohydrate ligand
for selectins. In addition, VCAM1 (CD106, vascular cell
adhesion molecule, up-regulated 5.46-fold in PBMC) is a
type I membrane protein that is important in cell-cell
recognition, and mediates leukocyte-endothelial cell adhe-
sion and signal transduction. ICAM proteins are type I
transmembrane glycoproteins that bind to the leukocyte
adhesion protein LFA-1. ICAM-1 (CD54, intercellular
adhesion molecule-1, up-regulated 5.77-fold in brain and
3.43-fold in PBMC) is typically expressed on endothelial
cells and cells of the immune system and binds to integ-
rins of type CD11a/CD18, or CD11b/CD18. It alters shear
stress stimulated up-regulation of endothelial VCAM-1
and ICAM-1 in a BMP-4 and TGF-beta1-dependent path-
way. In addition, ICAM-2 (CD102, intercellular adhesion
Table 1 Verification of differentially expressed genes via
qRT-PCR
Tissues Genes Microarray FC
a qRT-PCR FC p value
d
Brain ICAM-1 +5.77 +
b 6.00 0.0129
TLR2 +3.86 +19.89 0.0301
CD163 +8.91 +179.61 0.0158
TTR -
c 12.83 -10.92 0.0023
VEGFA +1.55 -4.20 0.0461
Lung ICAM-1 +1.97 +55.50 0.0133
TLR2 +2.44 +25.59 0.0216
CD163 +4.25 +11.30 0.0056
TTR -1.05 -7.69 0.0292
VEGFA -2.22 -3.45 0.0201
PBMC ICAM-1 +3.16 +13.13 0.0075
TLR2 +2.70 +8.57 0.0132
CD163 +9.08 +3.39 0.0243
TTR -1.07 -0.69 0.0055
VEGFA -2.71 -1.27 0.0332
aFold Change.
bRepresents up regulation.
cRepresents down regulation.
dSignificance level of differential expression for a particular gene via qRT-PCR.
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Page 4 of 12molecule-2, up-regulated 3.55-fold in brain) plays a role in
the cellular interactions associated with xenograft rejec-
tion, by blocking LFA-1-dependent cell adhesion in lym-
phocyte recirculation, and mediates adhesive interactions
that are important for antigen-specific immune responses
and surveillance. Another CAM, CD18 (ITGB2, integrin,
beta 2 (complement component 3 receptor 3 and 4 subu-
nit, up-regulated 2.13-fold in brain), is a receptor for
ICAM1, ICAM2, ICAM3 and ICAM4, and combines with
ITGAM or ITGAX to form a leukocyte-specific integrin
called macrophage receptor 1 (Mac-1), or inactivated-C3b
(iC3b) receptor 3 (CR3).
The selectins are Ca
2+-dependent CAMs that bind fuco-
sylated carbohydrates. SELE (selectin E, CD62E antigen,
up-regulated 4.82-fold in lung) encodes proteins that are
found in cytokine-stimulated endothelial cells and is
thought to mediate the adhesion of blood neutrophils to
cytokine-activated endothelium through interaction with
PSGL1/SELPLG. SELL (selectin L, CD62L antigen, up-
regulated 3.90-fold in lung) is a cell surface adhesion pro-
tein which mediates the adherence of lymphocytes to
endothelial cells of high endothelial venules in peripheral
lymph nodes and promotes the initial tethering and rolling
of leukocytes in endothelia. SELP (CD62P antigen, selectin
P, up-regulated 2.69-fold in brain) encodes a 140 kDa pro-
tein that is stored in the alpha-granules of platelets and
Weibel-Palade bodies of endothelial cells, and mediates
the interaction of activated endothelial cells or platelets
with leukocytes.
Antigen processing and presentation
Antigen processing and presentation is performed by
antigen presenting cells that express antigen (peptide or
lipid) on their cell surface in association with an MHC
protein complex. The MHC protein complex is a trans-
membrane protein complex composed of an MHC alpha
chain and, in most cases, either an MHC class II beta
chain or an invariant beta2-microglobin chain, with or
without a bound peptide, lipid or polysaccharide antigen.
Multiple MHC proteins were identified as DE genes after
infection with S. suis 2. SLA-1 (Sus scrofa MHC class I
a n t i g e n1 ,P D 1 ,3 - f o l dd o w n - r e g u l a t e di nb r a i n )i s
involved in the presentation of foreign antigens to cells of
the immune system. SLA-6 (Sus scrofa MHC class I anti-
gen 6, 2-fold down-regulated in PBMC) is similar to the
gene HLA-G of Homo sapiens.S L A - D R A( Sus scrofa
MHC class II antigen DR-alpha, 3.7-fold up-regulated in
brain) is similar to HLA-DRA, does not have polymorph-
isms in the peptide binding portion and acts as the sole
alpha chain for DRB1, DRB3, DRB4 and DRB5. SLA-
DRB1 (Sus scrofa MHC class II histocompatibility antigen
SLA-DRB1, 2.8-fold up-regulated in brain, 3.8-fold down-
regulated in PBMC and 4.5-fold down-regulated in lung)
contains all the polymorphisms that specify the peptide
binding and is present in all individuals. The protein
encoded by SLA-DQA1 (Sus scrofa MHC class II histo-
compatibility antigen SLA-DQA, 3.2-fold up-regulated in
brain), and SLA-DQB1 (Sus scrofa SLA-DQ beta1, 4-fold
up-regulated in brain) are two proteins that are required
to form the DQ heterodimer, similar to HLA-DQA1 and
HLA-DQB1. SBAB-1044B7.2 (SLA-DMB, Sus scrofa
MHC class II, DM beta, down-regulated 2.59-fold in
PBMC) is similar to HLA-DMB and is located in intracel-
lular vesicles, plays a critical role in catalyzing the release
of class II-associated invariant chain peptide (CLIP) from
newly synthesized MHC class II molecules and frees the
peptide binding site for acquisition of antigenic peptides.
In B cells, the interaction between HLA-DM and MHC
class II molecules is regulated by HLA-DO. SLA-DOA
(major histocompatibility complex, class II, DO alpha,
HLA-DMA, SLA-DMA, SLA-DOA) was 3-fold up-regu-
lated in brain. TAP1 (Transporter 1, ATP-binding cas-
sette, sub-family B (MDR/TAP), up-regulated 4.24-fold
in brain and 2.14-fold in lung) belongs to the ABC (ATP-
binding cassette) transporter family, is involved in the
transport of antigens from the cytoplasm to the endo-
plasmic reticulum for association with MHC class I
molecules, and acts as a molecular scaffold for the final
stage of MHC class I folding, namely the binding of
peptide.
Cytokine activity
Cytokines function in control of the survival, growth, differ-
entiation and effector function of tissues and cells that par-
ticipate in the immune and inflammatory responses.
Interleukins are a group of cytokines that are produced by
white blood cells (leukocytes) and a wide variety of somatic
cells. Monocytes, macrophages and endothelial cells pro-
mote the development and differentiation of T, B and other
hematopoietic cells, and play an important role in the
immune system. The results of this study showed that IL1A
was up-regulated 5.6-fold in PBMC. IL1B was up-regulated
7.6-fold in lung. IL6 was up-regulated 4.4-fold in lung. IL8
was up-regulated 4.6-fold in lung. IL12B was up-regulated
13.8-fold in PBMC and 3.4-fold in lung. IL15 was up-regu-
lated 3-fold in brain. IL18 was up-regulated 2.7-fold in
lung. IL10RB (interleukin-10 receptor subunit beta, up-
regulated 2.1-fold in brain, 3.8-fold in PBMC and 3.5-fold
in lung) belongs to the cytokine receptor family; coexpres-
sion with IL10RA proteins has been shown to be required
for IL10-induced signal transduction. TNF-a (tumor necro-
sis factor-alpha, up-regulated 4.0-fold in PBMC and 2.9-
fold in lung) is a cytokine secreted mainly by macrophages,
which is involved in a wide spectrum of biological processes
including cell proliferation, differentiation and apoptosis
and has been implicated in a variety of diseases, including
autoimmune diseases, insulin resistance, and cancer. CD40
(up-regulated 3.3-fold in brain and 3-fold in lung) is a
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variety of immune and inflammatory responses. SR-PSOX
(scavenger receptor for phosphatidylserine and oxidized
low density lipoprotein (OxLDL), up-regulated 7.08-fold in
PBMC) is a scavenger receptor on macrophages, binds to
CXCR6/Bonzo and binds specifically to OxLDL, which sug-
gests that it may induce a strong chemotactic response and
induce calcium mobilization.
Furthermore, many cytokines are involved in signaling
systems. STAT1 (signal transducer and activator of tran-
scription 1, up-regulated 3.6-fold in brain and 2.4-fold in
lung), STAT2 (up-regulated 2.09-fold in brain), STAT3
(up-regulated 2.36-fold in brain) and STAT5A (up-regu-
lated about 2-fold in all three tissues) belong to the STAT
family, which is usually activated by Janus kinase (JAK)
and dysregulation. They regulate growth, survival and dif-
ferentiation in cells. JAK2 (Janus kinase 2, up-regulated
2.2-fold in PBMC) is required for the response to IFN-g.
IKBKG (inhibitor of kappa light polypeptide gene enhan-
cer in B-cells, kinase gamma, up-regulated 2-fold in brain),
also known as NEMO and IKK-g, is the regulatory subunit
of the inhibitor of the IB kinase (IKK) complex and inter-
acts with IKK-alpha and IKK-beta to activate nuclear fac-
tor-kappa-B and other pathways. NFKBIA (nuclear factor
of kappa light polypeptide gene enhancer in B-cells inhibi-
tor, alpha, IBa, up-regulated 3-fold in brain and 2.2-fold
in lung) is one member of a family of cellular proteins that
inhibit the NF-B transcription factor. TGFB1 (transform-
ing growth factor, beta 1, up-regulated 2.79-fold in brain)
is a member of the transforming growth factor beta
(TGFB) family of cytokines, which are multifunctional
peptides that regulate proliferation, differentiation, adhe-
sion, migration and other functions in many cell types.
TBK1 (TANK-binding kinase 1, up-regulated 2-fold in
PBMC) is similar to IKB kinases and can mediate NFKB
activation, including the phosphorylation and activation of
IRF3 and IRF7.
Angiogenesis
Angiogenesis is a biological process of blood vessel forma-
tion in which new vessels emerge from the proliferation of
pre-existing blood vessels. VEGF is a growth factor that
induces endothelial cell proliferation, promotes cell migra-
tion, inhibits apoptosis and induces permeabilization of
blood vessels. It was down-regulated 2.7-fold in PBMC
and 2.2-fold in lung. Two other angiopoietic factors that
were down-regulated in lung in our study were ANGPT1
and its receptor TEK (TIE2). ANGPT1 can activate TIE2
by inducing tyrosine phosphorylation, and participates in
the endothelial developmental processes later than and
distinct from VEGF. It plays a crucial role in mediating
the interactions of endothelium and the surrounding
matrix and mesenchyme, and also mediates blood vessel
maturation/stability [17]. These results indicate that
infection with S. suis 2 may influence the maturation and
stability of blood vessels.
Discussion
Streptococcus suis infection is considered a major problem
in the global pig industry and has caused mass mortality
in pigs, particularly during the past 20 years [1]. Studies of
the pathogenesis of this infection have generally used
human macrophages, porcine choroid plexus epithelial
cells (PCPEC) or porcine brain microvascular endothelial
cells to investigate the host response to S. suis 2 in vitro.
Recently, Li et al. analyzed swine spleen infected with SS2
[18]. While these results strengthened our understanding
of the pathogenetic mechanisms of the bacterium, the
mechanism of the interaction between S. suis 2a n dt h e
host remained unclear. In this study we investigated
changes in gene expression in the brain, lung and PBMC
of pigs in response to S. suis 2 infection.
Differential expression in all three tissues
Our analysis found 31 genes to be differentially expressed
in infected and non-infected brain, lung and PBMC (Table
2). Most of these genes were associated with the innate
immune system. In previous studies, CD163 has been dis-
covered to be a cellular receptor for PRRSV in CD14 posi-
tive cells and to mediate viral entry and uncoating [19,20].
Other studies have revealed that CD163 can be a macro-
phage receptor for the binding of bacteria [21] and that it
can promote bacteria-induced production of proinflamma-
tory cytokines during infection [22,23]. These findings
indicate that CD163 may have a function in microbial
infection. A further study showed that CD163 was asso-
ciated with S. suis 2 infection [9]. However, the function of
CD163 in this setting was unclear. In our study, up-regu-
lated expression of CD163 was detected in all three
infected tissues. Other studies have shown that up-regula-
tion of CD163 can be induced by IL-10 and IL-6, and con-
comitantly influenced by multiple cytokines [24,25]. In
addition, expression of CD163 increases along the pathway
of macrophage differentiation [26,27]. Although IL-6 and
IL-10 are known to be induced by TLR2, their up-regula-
tion also affects CD163 up-regulation [28]. Human TLR2
can associate with CD14 and play an important role in
SS2 infection [15]. Given that CD163, TLR2 and CD14
were all found to be up-regulated in our study, in combi-
nation with other cytokines (IL6, IL10, etc.), we demon-
strate that these genes are involved in S. suis 2 infections.
The function of CD163 in S. suis 2 infection invites further
research.
Genes differentially expressed in PBMC
Infection with S. suis 2 in both pigs and humans can
cause fatal septicemia. Sepsis is a serious condition with
a significant morbidity and mortality, and has been
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a
Brain PBMC Lung
GeneBank ID Gene name Gene symbol p-value
b FC p-value FC p-value FC
NM_213857.1 TIMP metallopeptidase
inhibitor 1
TIMP1 8.10E-05 3.65181 7.18E-03 2.66352 8.08E-05 5.85375
NM_213771.1 interleukin 10 receptor,
beta
IL10RB 1.57E-02 2.11795 2.82E-04 3.85676 4.93E-04 3.5312
AF135122.1 signal transducer and
activator of transcription
5a
STAT5A 1.89E-02 2.52188 3.35E-02 2.26822 4.90E-02 2.1119
NM_213761.1 toll-like receptor 2 TLR2 5.34E-05 3.8551 7.47E-04 2.69655 1.68E-03 2.43616
BE232628 Similar to acetyl-
coenzyme A
acyltransferase 2
LOC100155327 2.26E-02 -2.18647 3.55E-02 -2.03229 2.94E-02 -2.09592
CF362301 similar to syntaxin 11 LOC100152253 7.32E-04 5.02375 2.36E-04 6.38426 2.29E-02 2.5498
BX917516 Similar to Histone H2A
type 1-C (H2A/l)
LOC100155325 3.90E-02 2.42467 5.21E-04 6.01862 6.21E-05 9.92759
U55068.1 solute carrier family 11
(proton-coupled divalent
metal ion transporters),
membe
SLC11A1 4.73E-03 2.51987 1.33E-03 3.03397 1.01E-03 3.1645
NM_214107.1 adrenomedullin ADM 3.01E-02 2.77106 2.67E-02 2.84834 8.15E-03 3.71455
NM_214127.1 superoxide dismutase 2,
mitochondrial
SOD2 5.53E-03 7.15851 1.43E-03 11.0196 2.19E-03 9.60376
BP161394 CD14 molecule CD14 3.31E-03 2.03944 3.19E-03 2.04785 1.00E-04 3.0381
NM_213976.1 CD163 molecule CD163 3.28E-07 8.90964 2.99E-07 9.0756 2.28E-05 4.25237
AJ663261 solute carrier family 2
(facilitated glucose
transporter), member 3
SLC2A3 8.45E-05 4.66825 2.26E-02 2.00129 2.66E-03 2.72289
CF368229 similar to Transcription
factor ETV7 (Transcription
factor Tel-2) (ETS-related
p
LOC100156210 2.05E-02 2.21213 8.86E-03 2.53106 2.92E-02 2.08944
NM_001005351.1 interferon
stimulated
exonuclease gene
20kDa
ISG20 3.11E-03 4.68553 1.48E-02 3.28837 1.54E-03
5.51054
BI402345 —— 4.97E-04 3.711 1.09E-03 3.27418 2.44E-03 2.88867
BQ603979 —— 5.78E-04 3.34979 3.55E-04 3.61029 8.69E-03 2.26328
CF180654 —— 1.18E-03 2.99848 2.09E-03 2.76134 1.13E-03 3.01962
CK457954 —— 1.06E-06 -11.761 1.33E-03 -3.10658 1.56E-03 -3.03402
BF079328 —— 1.84E-03 2.25759 2.51E-03 2.17989 7.8E-04 2.49339
BI402402 —— 4.92E-07 14.747 1.82E-06 10.7931 1.17E-02 2.27742
CO946796 —— 3.94E-06 -7.83105 4.95E-03 -2.42882 7.06E-03 -2.31103
BX924325 —— 6.55E-03 2.41774 1.08E-02 2.24747 9.32E-03 2.29727
BX926199 —— 4.86E-02 2.23094 1.14E-02 2.97827 8.5E-04 5.01781
CO953941 —— 4.74E-02 4.00916 9.42E-04 15.4413 5.59E-03 8.31723
BQ597849 —— 3.00E-04 -2.5804 2.70E-03 -2.03617 1.12E-03 -2.23346
BF443326 —— 2.75E-03 4.19593 1.18E-02 3.10382 6.91E-03 3.46603
CK457453 —— 1.95E-02 2.07169 2.39E-02 2.01081 1.77E-02 2.101
CN159527 —— 9.44E-03 2.61444 1.02E-02 2.57932 2.39E-04 4.98165
CO954523 —— 7.41E-03 -2.17839 8.56E-03 -2.13788 4.56E-03 -2.32115
BE232824 —— 4.42E-06 2.8712 9.60E-05 2.15173 8.74E-05 2.16904
aUp/down-regulated genes which annotation based on GO term.
bSignificance level of differential expression for a particular gene via microarray.
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and the systemic inflammatory response syndrome
(SIRS) [29]. S. suis 2 produces suilysin, which can result
in hemolysis of red blood cells and the release of hemo-
globin, and is toxic for epithelial cells [30,31], which
may allow invasion of the bloodstream. Free S. suis 2
cells or those in close contact with monocytes in the
bloodstream may cause septicemia.
Cytokines, including TNF-a, IL-1, IL-10 and IL-12, have
been shown to play an important role in septic shock
[31-34], and were found in the present study to be signifi-
cantly differentially expressed in PBMC after infection
with S. suis 2. Moreover, several scavenger receptor genes
were differentially expressed in PBMC after infection with
S. suis 2, when compared with brain and lung. SR-PSOX
(CXCL16) and Scarb2 were up-regulated only in PBMC.
CXCR6, up-regulated in both lung and PBMC, is a ligand
for CXCL16. CXCL16, and its ligand CXCR6, are involved
in interactions of DC with T cells and in the regulation of
T cell migration in the red pulp of the spleen; they are up-
regulated by inflammatory mediators [35]. CXCL16 is a
biomarker of inflammatory bowel disease and diseases
such as sarcoidosis and atherosclerosis. It is possible that
the scavenger receptor may play an important role in the
effects of S. suis 2 infection, especially septicemia. Another
gene, VEGF, is a growth factor that is active in angiogen-
esis and endothelial cell growth. In our study, this gene
was down-regulated, which suggests that S. suis 2 infection
may suppress vasculogenesis, endothelial cell proliferation
and cell migration, and may enhance the production of
septicemia by inhibition of VEGF expression,
Genes differentially expressed in brain
Meningitis is another important clinical manifestation of
S. suis 2 infection. After S. suis 2 bacteria enter the
bloodstream, they cause an overwhelming sepsis that
enables S. suis 2 to pass between or through the cells
that form the blood-brain barrier (BBB), allowing S. suis
2 to disseminate in the central nervous system (CNS).
In our results, several genes involved in antigen proces-
sing and presentation [36] showed differential expression
in porcine brain after S. suis 2 infection, but were
unchanged in PBMC and lung tissues. These genes
belonged mainly to the class of swine leukocyte antigens
(SLA), which is also called the swine major histocompat-
ibility complex (MHC). Recent research has demonstrated
that SLA molecules play an important role in porcine
immune responses to pathogens and vaccines [37].
Class I molecules, such as SLA-1, are found on almost
all cells and present proteins to cytotoxic T cells. They are
thought to be recognized by xenoantigens [37,38] and
have been implicated in human xenotransplantation [39]
and cancer diseases such as porcine melanoma [40]. Class
II molecules are found on certain immune cells, chiefly
antigen-presenting cells (APCs) such as macrophages and
B cells. They recognize non-self molecules, present the
fragments to helper T cells, and stimulate an immune
reaction. Class II molecules include SLA-DRA, SLA-
DRB1, SLA-DQA1, SLA-DQB1, SLA-DMB and SLA-
DOA. SLA Class II also has a function in CSFV (classical
swine fever virus) [41], PRRSV (porcine reproductive and
respiratory syndrome virus ) [42], and FMDV (foot and
mouth disease) [43] infections in pigs. In addition, cyto-
kines such as TNF-a, IFN-g and IL-4 have been shown to
regulate the expression of MHC class I and II antigens on
transplanted organs that are involved in immune
responses [44]. Human leukocyte antigens (HLA) have
been proven to be associated with many diseases, and can
inhibit lysis of NK cells in HIV infection by interacting
with their inhibitory receptors [45]. Therefore, the up-
regulated expression of cytokines and swine MHC mole-
cules (SLA) may play an important role during S. suis 2
infection.
Genes differentially expressed in lung
Pneumonia is another important clinical manifestation of
S. suis 2 infection. S. suis 2 can adhere to many cells in
vitro, including several types of epithelial cell, porcine
brain microvascular endothelial cells and alveolar macro-
phages [12,13,30]. Before it breaks through the epithelial
cell barrier to enter the bloodstream, S. suis 2n a t u r a l l y
colonizes the upper respiratory tract of pigs, particularly
the tonsils and nasal cavity [46]. It is transmitted via the
respiratory route by breaching the mucosal epithelium
and then enters the blood vessels [2]. The capsule of
S. suis 2 and suilysin secreted by S. suis 2m a yh e l pt h e
bacterium to evade macrophage phagocytosis and innate
immune responses [47,48]. In a previous study, S. suis 2
was shown to interact with alveolar macrophages and
induce the NF-kB and MAP-kinase signaling pathways.
In this study, we evaluated the differential expression of
genes in the lung in response to S. suis 2 infection.
According to our results, a group of cytokines showed
maximal up-regulation in the lung after infection with
S. suis 2. Of these, IL1B, IL-6, IL-8 and IL18 were up-
regulated only in lung, IL12B and TNF-a were more
highly expressed in both lung and PBMC, and IL10RB in
all three tissues. In addition, IL1A was up-regulated in
PBMC while IL15 was up-regulated in brain but not in
lung. These data are in agreement with other studies that
suggest that S. suis 2 can stimulate porcine monocytes or
macrophages to produce proinflammatory cytokines, and
thus contribute to the pneumonia caused by S. suis 2
infection. In addition, we have shown that MHC mole-
cules and adhesion molecules are critical in allowing
S. suis 2 to break through epithelial cell barriers to cause
pneumonia, although many of the DE genes involved are
little known in S. suis 2 infection.
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Global transcription studies have been performed to ana-
lyze the pathogenesis of many diseases. In this study, we
profiled the response of PBMC, brain and lung tissues to
infection with S. suis 2 strain SC19 using the Affymetrix
Porcine Genome Array. A total of 3,002 differentially
expressed transcripts were identified in the three tissues,
including 417 unique genes in brain, 210 in lung, 213 in
PBMC and 31 in all three tissues. These DE genes involve
in the immune response included genes related to the
inflammatory response, innate immune response, cell
adhesion, antigen processing and presentation, cytokines
and angiogenesis. In addition, a number of DE genes
identified in our study are still function unknown, pro-
viding information for future investigations. Taken
together, the transcriptome analysis of S. suis 2-infected
tissues will increase our knowledge of the pathogenesis of
meningitis, septicemia and pneumonia in pigs caused by
S. suis 2.
Methods
Bacterial strains and growth conditions
S. suis 2 strain SC19 was isolated from diseased pigs in the
Sichuan region of China in 2005. Bacteria were grown on
tryptic soy agar plates (DifcoTM) containing 10% bovine
blood overnight at 37°C, and inoculated into tryptic soy
broth (DifcoTM) containing 10% bovine blood for 6 h at
37°C. For experimental infection, the serum broth culture
was centrifuged at 3,300 × g for 5 min to pellet the bac-
teria, washed twice with phosphate-buffered saline (PBS),
and resuspended in PBS without serum to the appropriate
dilution before infection.
Animals and tissue collection
All animal tissues were collected in compliance with local
animal experimentation legislation and with approval of
the Biological Studies Animal Care and Use Committee
of Hubei Province (Y20100566). At 40 days of age, six
piglets free of S. suis 2 were allocated randomly to the
infected group and the uninfected group. Each piglet in
the infected group was injected intravenously with S. suis
2s t r a i nS C 1 9a tad o s eo f3 × 1 0
5 colony-forming units
(CFU). Each piglet in the uninfected group was treated
similarly with an identical volume of PBS as control. At
24 h after challenge, the pigs were slaughtered and their
brains, lungs and venous blood were collected with
RNase-free equipment for microarray analysis. The
brains and lungs from both groups were frozen immedi-
ately in liquid nitrogen. Venous blood were collected
with anticoagulant citrate concentrated solution 4%
(S5770, Sigma-Aldrich, St Louis, MO, USA) at a ratio of
9:1, and Histopaque (1077, Sigma-Aldrich) was used for
isolation of PBMC according to the manufacturer’s
instructions. Finally, the PBMC were resuspended with
isotonic PBS, and counted under a microscope. TRIzol
reagent (Invitrogen) was added at a suitable volume and
cells were stored at -80°C until used.
RNA extraction and reverse transcription
Total RNA extraction from tissues was performed
according to the standard instructions for TRIzol
reagent (Invitrogen, Carlsbad, CA, USA) and clean-up
was carried out using an RNeasy Mini Kit (Qiagen,
Valencia, CA, USA). The integrity and concentration of
RNA were evaluated using an Agilent 2100 Bioanalyzer
(Santa Clara, CA, USA). Reverse transcription of the
total RNA and synthesis of biotin-labeled cRNA with
one round of amplification was carried out following the
standard Affymetrix one-cycle protocol according to the
manufacturer’s instructions.
For qRT-PCR analysis, the tissues were ground to a
powder with liquid nitrogen and an RNAprep pure Tissue
Kit (DP431, TIANGEN, Beijing, China) was used for RNA
extraction and purification, following the manufacturer’s
instructions. The PBMC were prepared with TRIzol
reagent according to the TRIzol standard instructions
(Invitrogen). The RNA was quantified by spectrophotome-
try (ND-1000; NanoDrop Technologies). The total RNA
was reverse transcribed to cDNA using a first strand
cDNA synthesis kit (ReverTra Ace -a-TM, TOYOBO)
according to the manufacturer’s instructions.
Microarray hybridization
The RNA was labeled and hybridization was performed
using the recommended protocols supplied by the manu-
facturer (Affymetrix, Santa Clara, CA, USA), by Gene-
Tech Biotechnology Limited Company (Shanghai,
China). Briefly, a sample of RNA was converted to dou-
ble-stranded cDNA using a one-cycle cDNA Synthesis
Kit (Affymetrix, Inc., Santa Clara, CA) and a T7-oligo
(dT) primer. Synthesis of biotin-labeled cRNA from
cDNA by in vitro transcription (IVI) was conducted
using a GeneChip IVT Labeling Kit (Affymetrix). The
cDNA and cRNA were purified using the Sample
Cleanup Module (Affymetrix), quantified by spectropho-
tometric methods and checked by formaldehyde denatur-
ing gel electrophoresis in 1.2% agarose gels. The samples
were characterized by dispersed bands (28S and 18S)
without any obvious smearing patterns from degradation.
Subsequently, labeled cRNA was fractionated and hybri-
dized with the GeneChip Porcine Genome Array accord-
ing to the standard procedures provided by the
manufacturer. The chips were washed and stained with a
GeneChip Fluidics Station 450 (Affymetrix) using the
standard fluidics protocol. The probe arrays were
scanned using the Affymetrix
® GeneChip
® Scanner 3000.
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For analysis of the microarray data, the Affymetrix
expression data were analyzed using the software pack-
age Gene Spring, version 7.31 (Agilent). All experiments
were performed in triplicate to allow the assessment of
within-group variation. First, the expression data
obtained from infected cells were normalized to the
median of the uninfected control samples. An initial
selection of genes was made based on a 2-fold change in
expression relative to that of uninfected control cells.
Subsequently, an error model based on replicate mea-
surements was defined in Gene Spring, and the signifi-
cance of differential expression was established using
analysis of variance and the false-discovery rate method
of Benjamini and Hochberg [49] to correct for multiple
testing. Microarray analysis was then performed by Gen-
eTech Company using an Agilent gene chip array. The
data discussed in this study have been deposited in the
NCBI Gene Expression Omnibus with accession number
GSE24889.
Quantitative RT-PCR (qRT-PCR) analysis
QRT-PCR was used to validate selected data from the
microarray experiments and to follow the expression of a
subset of genes over time. Five genes with different expres-
sion patterns (up-regulated, down-regulated and no signif-
icant change) were randomly selected. These genes were
ICAM-1, TLR2, CD16, TTR and VEGFA. GAPDH (gly-
ceraldehyde-3-phosphate dehydrogenase) was used as a
endogenous control, designed using Primer Express 2.0
software (Applied Biosystems Inc., Foster City, CA, USA).
The specific primers used for the various qRT-PCR assays
are listed in Table 3. The SYBR Green method was used
for qRT-PCR amplification. All reactions were performed
in triplicate. Each reaction tube contained 25 μL2×S Y B R
Green real-time PCR Master Mix (TOYOBO QPK-201),
0.5 UmL
-1 RNAse Inhibitor, 0.3 UmL
-1 ReverTraAce, 0.4
mM gene-specific F and R primers and 5 μL template,
made up to a final volume of 50 μL with distilled water.
The qRT-PCR were performed in an ABI 7500 real-time
PCR system (Applied Biosystems, Warrington, UK) as fol-
lows: 42°C for 30 min and 95°C for 5 min, followed by 40
cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 45 s.
Melting curves were obtained from 55°C to 95°C, read
every 0.5 °C for 10s, than cooling at 25°C for 30s. The
melting curves were analyzed to prevent genomic DNA
amplification, and the PCR products were confirmed by
agarose gel electrophoresis (1.5%). Gene expression level
was calculated using the comparative Ct method [50]. The
duplicates for each reaction were averaged. Fold changes
value were calculated 2
-ΔΔCt which ΔΔCt = (Cttest gene-
Cttest GAPDH ) - (Ctcontrol gene-Ctcontrol GAPDH ). t tests were
performed to calculate statistical significance of genes
expression between the test group and control group.
Abbreviations
SS2: Streptococcus suis 2; DE: differentially expressed; FC: fold change; GO:
Gene Onotlogy; qRT-PCR: quantitative RT-PCR;
Acknowledgements
This work was supported by the Program for Changjiang Scholars and
Innovative Research Team in University (IRT0726), the New Century Excellent
Talent Project (NCET-07-0347), and the Key Technology R&D Programme of
China (2006BAD06A07).
Author details
1Division of Animal Pathogens, State Key Laboratory of Agricultural
Microbiology, Huazhong Agricultural University, Wuhan 430070, China.
2College of Veterinary Medicine, Huazhong Agricultural University, Wuhan
430070, China.
Authors’ contributions
ML and SX designed and performed the experiments. LF and CT made
bioinformatics and statistical analysis. TL participated in the animal challenge
experiment. The manuscript was written by ML, SX, and HC. All authors read
and approved the final manuscript.
Received: 25 November 2010 Accepted: 20 May 2011
Published: 20 May 2011
References
1. Gottschalk M, Xu J, Calzas C, Segura M: Streptococcus suis: a new
emerging or an old neglected zoonotic pathogen? Future Microbiol 2010,
5(3):371-391.
2. Gottschalk M, Segura M: The pathogenesis of the meningitis caused by
Streptococcus suis: the unresolved questions. Vet. Microbiol 2000,
76(3):259-272.
3. Feng Y, Zhang H, Ma Y, Gao GF: Uncovering newly emerging variants of
Streptococcus suis, an important zoonotic agent. Trends Microbiol 2010,
18(3):124-131.
4. Wangsomboonsiri W, Luksananun T, Saksornchai S, Ketwong K,
Sungkanuparph S: Streptococcus suis infection and risk factors for
mortality. J Infect 2008, 57(5):392-396.
5. Watkins EJ, Brooksby P, Schweiger MS, Enright SM: Septicaemia in a pig-
farm worker. Lancet 2001, 357(9249):38.
Table 3 Primers for qRT-PCR
Gene name Primer sequence (5’® 3’) GenBank ID
CD163 Forward: TCAGACACTATCCCCGTGCA Reverse: GGCGAAGTTGACCACTCCC NM_213976
ICAM-1 Forward: ACCCACACCTTGCTACCCCT Reverse: GTGGACCGTAGCCTCTGAGG NM_213816
TLR2 Forward: CCATCTTCGTGCTTTCCGAG Reverse: GGCGGTGTCATCGTTCTCAT NM_213761
TTR Forward: TCGCTGGACTGGTGTTTGTG Reverse: GGACTGCCTCGGACAGCAT NM_214212
VEGFA Forward: GAGACCAGAAACCCCACGAA Reverse: GGCAGTAGCTGCGCTGGTA NM_214084
GAPDH
a Forward: ACATGGCCTCCAAGGAGTAAGA Reverse: GATCGAGTTGGGGCTGTGACT AF017079
aGAPDH was used as a endogenous control.
Liu et al. BMC Genomics 2011, 12:253
http://www.biomedcentral.com/1471-2164/12/253
Page 10 of 126. van de Beek D, Spanjaard L, de Gans J: Streptococcus suis meningitis in
the Netherlands. J Infect 2008, 57(2):158-161.
7. Tramontana AR, Graham M, Sinickas V, Bak N: An Australian case of
Streptococcus suis toxic shock syndrome associated with occupational
exposure to animal carcasses. Med J Austm 2008, 188(9):538-539.
8. Smith TC, Capuano AW, Boese B, Myers KP, Gray GC: Exposure to
Streptococcus suis among US swine workers. Emerg Infect Dis 2008,
14(12):1925-1927.
9. Wilson SM, Norton P, Haverson K, Leigh J, Bailey M: Interactions between
Streptococcus suis serotype 2 and cells of the myeloid lineage in the
palatine tonsil of the pig. Vet Immunol Immunopathol 2007, 117(1-
2):116-123.
10. Chen C, Tang J, Dong W, Wang C, Feng Y, Wang J, Zheng F, Pan X, Liu D,
Li M, Song Y, Zhu X, Sun H, Feng T, Guo Z, Ju A, Ge J, Dong Y, Sun W,
Jiang Y, Wang J, Yan J, Yang H, Wang X, Gao GF, Yang R, Wang J, Yu J: A
glimpse of streptococcal toxic shock syndrome from comparative
genomics of S. suis 2 Chinese isolates. PLoS One 2007, 2(3):e315.
11. Lalonde M, Segura M, Lacouture S, Gottschalk M: Interactions between
Streptococcus suis serotype 2 and different epithelial cell lines.
Microbiology 2000, 146(8):1913-1921.
12. Vanier G, Segura M, Friedl P, Lacouture S, Gottschalk M: Invasion of porcine
brain microvascular endothelial cells by Streptococcus suis serotype 2.
Infect Immun 2004, 72(3):1441-1449.
13. Charland N, Nizet V, Rubens CE, Kim KS, Lacouture S, Gottschalk M:
Streptococcus suis serotype 2 interactions with human brain
microvascular endothelial cells. Infect Immun 2000, 68(2):637-643.
14. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C,
Keck S, Galanos C, Freudenberg M, Beutler B: CD14 is required for MyD88-
independent LPS signaling. Nat Immunol 2005, 6(6):565-670.
15. Segura M, Vadeboncoeur N, Gottschalk M: CD14-dependent and
-independent cytokine and chemokine production by human THP-1
monocytes stimulated by Streptococcus suis capsular type 2. Clin Exp
Immunol 2002, 127(2):243-254.
16. Rikitake Y, Takai Y: Interactions of the cell adhesion molecule nectin with
transmembrane and peripheral membrane proteins for pleiotropic
functions. Cell Mol Life Sci 2008, 65(2):253-263.
17. Glinskii OV, Abraha TW, Turk JR, Rubin LJ, Huxley VH, Glinsky VV:
Microvascular network remodeling in dura mater of ovariectomized
pigs: role for angiopoietin-1 in estrogen-dependent control of vascular
stability. Am J Physiol Heart Circ Physiol 2007, 293(2):H1131-H1137.
18. Li R, Zhang A, Chen B, Teng L, Wang Y, Chen H, Jin M: Response of swine
spleen to Streptococcus suis infection revealed by transcription analysis.
BMC Genomics 2010, 11:556.
19. Calvert JG, Slade DE, Shields SL, Jolie R, Mannan RM, Ankenbauer RG,
Welch SK: CD163 expression confers susceptibility to porcine
reproductive and respiratory syndrome viruses. J Virol 2007,
81(14):7371-7379.
20. Patton JB, Rowland RR, Yoo D, Chang KO: Modulation of CD163 receptor
expression and replication of porcine reproductive and respiratory
syndrome virus in porcine macrophages. Virus Res 2009, 140(1-2):161-171.
21. Van den Heuvel MM, Tensen CP, van As JH, Van den Berg TK, Fluitsma DM,
Dijkstra CD, Döpp EA, Droste A, Van Gaalen FA, Sorg C, Högger P,
Beelen RH: Regulation of CD 163 on human macrophages: cross-linking
of CD163 induces signaling and activation. J Leukoc Biol 1999,
66(5):858-866.
22. Fabriek BO, van Bruggen R, Deng DM, Ligtenberg AJ, Nazmi K,
Schornagel K, Vloet RP, Dijkstra CD, van den Berg TK: The macrophage
scavenger receptor CD163 functions as an innate immune sensor for
bacteria. Blood 2009, 113(4):887-892.
23. Polfliet MM, Fabriek BO, Daniëls WP, Dijkstra CD, van den Berg TK: The rat
macrophage scavenger receptor CD163: expression, regulation and role
in inflammatory mediator production. Immunobiology 2006, 211(6-
8):419-425.
24. Sulahian TH, Högger P, Wahner AE, Wardwell K, Goulding NJ, Sorg C,
Droste A, Stehling M, Wallace PK, Morganelli PM, Guyre PM: Human
monocytes express CD163, which is upregulated by IL-10 and identical
to p155. Cytokine 2000, 12(9):1312-1321.
25. Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM: Up-regulation of
human monocyte CD163 upon activation of cell-surface Toll-like
receptors. J Leukoc Biol 2007, 81(3):663-671.
26. Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G: Regulation
of scavenger receptor CD163 expression in human monocytes and
macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 2000,
67(1):97-103.
27. Sánchez C, Doménech N, Vázquez J, Alonso F, Ezquerra A, Domínguez J:
The porcine 2A10 antigen is homologous to human CD163 and related
to macrophage differentiation. J Immunol 1999, 162(9):5230-5237.
28. Yang RB, Mark MR, Gurney AL, Godowski PJ: Signaling events induced by
lipopolysaccharide-activated toll-like receptor 2. J Immunol 1999,
163(2):639-643.
29. Gaïni S, Pedersen SS, Koldkaer OG, Pedersen C, Moestrup SK, Møller HJ:
New immunological serum markers in bacteraemia: anti-inflammatory
soluble CD163, but not proinflammatory high mobility group-box 1
protein, is related to prognosis. Clin Exp Immunol 2008, 151(3):423-431.
30. Norton PM, Rolph C, Ward PN, Bentley RW, Leigh JA: Epithelial invasion
and cell lysis by virulent strains of Streptococcus suis is enhanced by the
presence of suilysin. FEMS Immunol Med Microbiol 1999, 26(1):25-35.
31. Gottschalk MG, Lacouture S, Dubreuil JD: Characterization of Streptococcus
suis capsular type 2 haemolysin. Microbiology 1995, 141(1):189-195.
32. Norrby-Teglund A, Pauksens K, Norgren M, Holm SE: Correlation between
serum TNF alpha and IL6 levels and severity of group A streptococcal
infections. Scand J Infect Dis 1995, 27(2):125-130.
33. Pruitt JH, Copeland EM, Moldawer LL: Interleukin-1 and interleukin-1
antagonism in sepsis, systemic inflammatory response syndrome, and
septic shock. Shock 1995, 3(4):235-251.
34. Mancuso G, Cusumano V, Genovese F, Gambuzza M, Beninati C, Teti G:
Role of interleukin 12 in experimental neonatal sepsis caused by group
B streptococci. Infect Immun 1997, 65(9):3731-3735.
35. Matloubian M, David A, Engel S, Ryan JE, Cyster JG: A transmembrane CXC
chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000,
1(4):298-304.
36. Ho CS, Lunney JK, Ando A, Rogel-Gaillard C, Lee JH, Schook LB, Smith DM:
Nomenclature for factors of the SLA system, update 2008. Tissue Antigens
2009, 73(4):307-315.
37. Lunney JK, Ho CS, Wysocki M, Smith DM: Molecular genetics of the swine
major histocompatibility complex, the SLA complex. Dev Comp Immunol
2009, 33(3):362-374.
38. Olack B, Manna P, Jaramillo A, Steward N, Swanson C, Kaesberg D,
Poindexter N, Howard T, Mohanakumar T: Indirect recognition of porcine
swine leukocyte Ag class I molecules expressed on islets by human CD4
+ T lymphocytes. J Immunol 2000, 165(3):1294-1299.
39. Ramachandran S, Jaramillo A, Xu XC, McKane BW, Chapman WC,
Mohanakumar T: Human immune responses to porcine endogenous
retrovirus-derived peptides presented naturally in the context of porcine
and human major histocompatibility complex class I molecules:
implications in xenotransplantation of porcine organs. Transplantation
2004, 77(10):1580-1588.
40. Tissot RG, Beattie CW, Amoss MS Jr, Williams JD, Schumacher J: Common
swine leucocyte antigen (SLA) haplotypes in NIH and Sinclair miniature
swine have similar effects on the expression of an inherited melanoma.
Anim Genet 1993, 24(3):191-193.
41. Bauhofer O, Summerfield A, McCullough KC, Ruggli N: Role of double-
stranded RNA and Npro of classical swine fever virus in the activation of
monocyte-derived dendritic cells. Virology 2005, 343(1):93-105.
42. Nielsen J, Bøtner A, Tingstedt JE, Aasted B, Johnsen CK, Riber U, Lind P: In
utero infection with porcine reproductive and respiratory syndrome
virus modulates leukocyte subpopulations in peripheral blood and
bronchoalveolar fluid of surviving piglets. Vet Immunol Immunopathol
2003, 93(3-4):135-151.
43. Bautista EM, Ferman GS, Gregg D, Brum MC, Grubman MJ, Golde WT:
Constitutive expression of alpha interferon by skin dendritic cells
confers resistance to infection by foot-and-mouth disease virus. J Virol
2005, 79(8):4838-4847.
44. Shirwan H, Barwari L, Khan NS: Predominant expression of T helper 2
cytokines and altered expression of T helper 1 cytokines in long-term
allograft survival induced by intrathymic immune modulation with
donor class I major histocompatibility complex peptides. Transplantation
1998, 66(12):1802-1809.
45. Gardiner CM: Killer cell immunoglobulin-like receptors on NK cells: the
how, where and why. Int J Immunogenet 2008, 35(1):1-8.
Liu et al. BMC Genomics 2011, 12:253
http://www.biomedcentral.com/1471-2164/12/253
Page 11 of 1246. Lun ZR, Wang QP, Chen XG, Li AX, Zhu XQ: Streptococcus suis:a n
emerging zoonotic pathogen. Lancet Infect Dis 2007, 7(3):201-209.
47. Chabot-Roy G, Willson P, Segura M, Lacouture S, Gottschalk M:
Phagocytosis and killing of Streptococcus suis by porcine neutrophils.
Microb Pathog 2006, 41(1):21-32.
48. Smith HE, Damman M, van der Velde J, Wagenaar F, Wisselink HJ,
Stockhofe-Zurwieden N, Smits MA: Identification and characterization of
the cps locus of Streptococcus suis serotype 2: the capsule protects
against phagocytosis and is an important virulence factor. Infect Immun
1999, 67(4):1750-1756.
49. Benjamini Y, Hochberg Y: Controlling the false discovery rate–a practical
and powerful approach to multiple testing. Stat. Soc 1995, 57(1):289-300.
50. Pfaffl MW: A new mathematical model for relative quantification in real-
time RT-PCR. Nucleic Acids Res 2001, 29(9):e45.
doi:10.1186/1471-2164-12-253
Cite this article as: Liu et al.: Understanding Streptococcus suis serotype
2 infection in pigs through a transcriptional approach. BMC Genomics
2011 12:253.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Liu et al. BMC Genomics 2011, 12:253
http://www.biomedcentral.com/1471-2164/12/253
Page 12 of 12